Answer: Published studies report few side effects, but BPC-157 is not FDA-approved and human safety data are limited, so it should be used only under medical supervision with a full medication review
After blocking in 5% skimmed milk powder for 2 hours at room temperature, the samples were incubated overnight at 4C with primary antibodies, including ERK1/2 (#9102), p-ERK1/2 (#9101), JNK1/2 (#9252), p-JNK (#9251), p38 MAPK (#9212), and p-p38 MAPK (#9211), which were obtained from Cell Signaling Technology (Beverly, MA, USA), as well as VEGF-a (sc-7269) and Tubulin (sc-8035), which were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA)
Using the printed batch number and QR code, customers can access our Advanced COA Verification System to review relevant batch-specific documentation where available
A: DopeRx BPC-157 is intended for parenteral (injection) use and must be administered by a healthcare professional as per prescribed guidelines